Funding Rounds
Orasis Pharmaceuticals October 2024 Series D Funding Round
Orasis PharmaceuticalsOrasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Summary
Stage: Series D
Raised Amount: $68.00M
Raised Date: 2024-10-08
